Benchling
Cloud-based software platform for life sciences R&D that provides integrated tools for molecular biology, sample management, inventory tracking, and collaboration for biotech and pharmaceutical companies.
Notes
Benchling is a leading life sciences R&D cloud platform that has transformed how scientists manage their research workflows. The platform provides integrated tools for molecular biology, including sequence design, CRISPR guide design, and plasmid management, along with electronic lab notebooks (ELN), sample management, and inventory tracking.
The company has grown rapidly to become the standard R&D platform for many of the world's leading biotech and pharmaceutical companies, with over 200,000 scientists using the platform globally. Benchling raised a significant Series F funding round with participation from Altimeter Capital.
Team
- Sajith Wickramasekara - Co-Founder and CEO
- Ashu Singhal - Co-Founder and CTO
- Eric Lai - Chief Financial Officer
- Sam Santhanam - Chief Revenue Officer
Additional Research Findings
- Over 200,000 scientists use the platform globally
- Co-led Series F funding round with Altimeter Capital
- Cloud-native R&D platform for life sciences
- Key features: molecular biology tools, ELN, sample management, inventory
- Customers include leading pharma and biotech companies
- YC Combinator alum (W12)
- Headquarters in San Francisco with global presence
- Significant market share in biotech R&D software
Sources
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Altimeter Capital | Menlo Park, USA | generalist | series-cgrowth | 2 |